Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Planet 13 HoldingsPLNH +0.83%31 3-Year EPS without NRI Growth Rate is 10.10% as of Jun. 2026. GuruFocus rates PLNH with a GF Score™ of 31/100 and a GF Value™ of $0.24 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 787 Drug Manufacturers companies, Planet 13 Holdings ranks better than 51.08% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was 10.10% per year.
During the past 5 years, the average EPS without NRI Growth Rate was -6.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 10 years, the highest 3-Year average EPS without NRI Growth Rate of Planet 13 Holdings was 10.10% per year. The lowest was -46.50% per year. And the median was -17.40% per year.
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Planet 13 Holdings 3-Year EPS without NRI Growth Rate Related Terms
PLNH vs ZTS: 3-Year EPS without NRI Growth Rate Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Planet 13 Holdings's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Planet 13 Holdings 3-Year EPS without NRI Growth Rate vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Planet 13 Holdings's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Planet 13 Holdings's 3-Year EPS without NRI Growth Rate falls into.
Planet 13 Holdings 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 10.10% mean?
Planet 13 Holdings (PLNH) has a 3-Year EPS without NRI Growth Rate of 10.10% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Planet 13 Holdings and its competitors. According to the industry distribution chart, Planet 13 Holdings ranks #385 out of 787 companies in the Drug Manufacturers industry, placing it in the top 48.9%.
Is Planet 13 Holdings' 3-Year EPS without NRI Growth Rate too high?
Planet 13 Holdings' current 3-Year EPS without NRI Growth Rate is 10.10%. The Drug Manufacturers industry median 3-Year EPS without NRI Growth Rate is 9.70. Planet 13 Holdings' value of 10.10% is 4.1% above this industry median. Based on the distribution chart, Planet 13 Holdings ranks #385 out of 787 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Planet 13 Holdings has a GF Score™ of 31/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Planet 13 Holdings' 3-Year EPS without NRI Growth Rate compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Planet 13 Holdings ranks #385 out of 787 companies for 3-Year EPS without NRI Growth Rate. This puts Planet 13 Holdings in the upper half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 9.70. Planet 13 Holdings' value of 10.10% is 4.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Drug Manufacturers company?
The median 3-Year EPS without NRI Growth Rate among Drug Manufacturers companies is 9.70, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Planet 13 Holdings's current 3-Year EPS without NRI Growth Rate of 10.10% is 4.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Planet 13 Holdings and its competitors. For the Drug Manufacturers industry, the median 3-Year EPS without NRI Growth Rate is 9.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Planet 13 Holdings's current 3-Year EPS without NRI Growth Rate is 10.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Planet 13 Holdings stock overvalued right now?
Based on GuruFocus' analysis, Planet 13 Holdings (PLNH) is currently considered Possible Value Trap. The stock's GF Value™ is $0.24, compared to a current price of $0.15 — trading 39.6% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 10.10% and 4.1% above the Drug Manufacturers industry median of 9.70. Planet 13 Holdings' overall GF Score™ is 31/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Planet 13 Holdings (PLNH), the current 3-Year EPS without NRI Growth Rate is 10.10% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Planet 13 Holdings (PLNH) Overvalued in 2026?
Based on GuruFocus' analysis, Planet 13 Holdings stock appears to be undervalued.
The current stock price of $0.15 is trading 39.6% below its estimated GF Value™ of $0.24.
GuruFocus considers Planet 13 Holdings to be Possible Value Trap.
Key valuation signals for PLNH:
3-Year EPS without NRI Growth Rate: 10.10%
GF Value™: $0.24 vs. price of $0.15 (39.6% below fair value)
Industry Position: 4.1% above the Drug Manufacturers median (#385 of 787)
No single metric tells the full story. See the PLNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Planet 13 Holdings Inc a vertically integrated cultivator and provider of cannabis and cannabis-infused products in the States of Nevada and California, with retail cannabis operations in Illinois. The company owns and manufactures cannabis products under the following brands: HaHa (gummies and beverages), Dreamland (chocolates), TRENDI (vapes and concentrates), Medizin (flower, vapes, concentrates), Leaf and Vine (vapes).
31GF Score
Get the complete analysis for PLNH
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLNH has been successfully added to your 
